EGFR expression in COVID19 placentas
Abstract
Introduction: Coronavirus disease 2019 (COVID-19) pandemic is a global health problem that has claimed many lives worldwide. The disease is affecting almost all populations, but it poses a particular risk for groups such as the elderly and those with chronic diseases. Although the number of studies on clinical situations involving pregnant women and their infants infected with COVID-19 is increasing, the factors supporting the negative association between COVID-19 and pregnancy remain unclear. In this study, we aimed to examine the placental histopathologic structure using EGFR (Epidermal Growth Factor) antibody in placentas of COVID-19 pregnant patients.
Materials and methods: In our study, placentas of a total of 40 pregnant women (regardless of age), including 20 pregnant women with C0VID-19 and 20 normotensive pregnant women, were used, and placentas were compared histopathologically and immunohistochemically.
Results: In the hematoxylin and eosin stained sections of the control group placentas, tissue integrity was preserved and cellular structures were normal. In the placentas of Covid -19 group patients, it was observed that degenerations increased and cellular deformations developed. In sections of control group placentas, EGFR expression was negative in decidual cells and in areas with syncytial nodes. EGFR expression was positive in cytotrophoblast cells. In placenta sections of Covid-19 patients, EGFR expression was positive in vascular endothelium and Hofbauer cells.
Conclusion: In our study, it was observed that EGFR expression, an important biomarker in tissue regeneration, was inhibited. We also concluded that Covid-19 caused degeneration and inflammation in placental tissue.
Keywords:
Covid-19, Placenta, EGFR, Pregnancy, HistopathologyDOI
https://doi.org/10.22270/jddt.v13i10.6237References
(1) 1- Fox, D. (2020). What you need to know about the novel coronavirus. Nature (Lond.) https://doi.org/10.1038/d41586-020-00209-y
(2) Golden TN, Simmons RA. Maternal and neonatal response to COVID-19. Am J Physiol Endocrinol Metab. 2020;319(2):E315-E319. https://doi.org/10.1152/ajpendo.00287.2020 PMid:32574110 PMCid:PMC7381709
(3) Baergen RN, Heller DS. Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings. Pediatr Dev Pathol. 2020;23(3):177-180. https://doi.org/10.1177/1093526620925569 PMid:32397896 PMCid:PMC7252218
(4) Özdemir, Ö., & Ayşegül, P. Diagnosis, treatment and prevention of Covid-19 infection in children. Journal of Biotechnology and Strategic Health Research, 2020;4:14-21. https://doi.org/10.34084/bshr.711208
(5) Dong L, Tian J, He S, et al. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn [published online ahead of print, 2020 Mar 26]. JAMA. 2020;323(18):1846-1848. https://doi.org/10.1001/jama.2020.4621 PMid:32215581 PMCid:PMC7099527
(6) Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental Pathology in COVID-19. Am J Clin Pathol. 2020;154(1):23-32. https://doi.org/10.1093/ajcp/aqaa089 PMid:32441303 PMCid:PMC7279066
(7) Handwerger, S. and M. Freemark, The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab, 2000;13(4):343-56. https://doi.org/10.1515/JPEM.2000.13.4.343 PMid:10776988
(8) Gauster M, Moser G, Orendi K, Huppertz B. Factors involved in regulating trophoblast fusion: potential role in the development of preeclampsia. Placenta 2009;30: 49-54 https://doi.org/10.1016/j.placenta.2008.10.011 PMid:19027159
(9) Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. https://doi.org/10.1056/NEJMoa2001017 PMid:31978945 PMCid:PMC7092803
(10) Taş, A., & Baloğlu, M. Post-COVID syndrome and pain perception in outpatients with COVID-19. European Review for Medical & Pharmacological Sciences, 2023;27(14).
(11) WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2022 May 6]. Available from: https://covid19.who.int
(12) Tas F., Yılmaz M., Erdemci, F., Asır, F., & Deveci, E. Examining the long-term effects of COVID-19 on the umbilical cord. Journal of Health Sciences and Medicine, 2022;5(5):1371-1377. https://doi.org/10.32322/jhsm.1138691
(13) Taş, F., Erdemci̇, F., Yilmaz, M., Aşir, F., Özüdoğru, O., & Deveci̇, E. Acute and long-term pathological effects of COVID-19 on the placenta during second trimester and labor. Revista de Investigaciones Universidad del Quindío, 2023;35(1):228-235. https://doi.org/10.33975/riuq.vol35n1.1154
(14) Ekinci, A., Aktas, A., Dönder, A., Ekinci, C., Turgut, A., Deveci, S., ... & DEVECI, E. Expression of endothelin-1 and Ki-67 in normotensive and severe preeclamptic placentas. Int. j. morphol, 2018;36(1):109-112. https://doi.org/10.4067/S0717-95022018000100109
(15) Robbins JR, Bakardjiev AI. Pathogens and the placental fortress. Curr Opin Microbiol. 2012;15(1):36-43. https://doi.org/10.1016/j.mib.2011.11.006 PMid:22169833 PMCid:PMC3265690
(16) Jing Y, Run-Qian L, Hao-Ran W, et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020;26(6):367-73. https://doi.org/10.1093/molehr/gaaa030 PMid:32365180 PMCid:PMC7239105
(17) Khong TY, Mooney EE, Ariel I, et al. Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140(7):698-713. https://doi.org/10.5858/arpa.2015-0225-CC PMid:27223167
(18) Linehan L, O'Donoghue K, Dineen S,et al. SARSCoV-2 placentitis: An uncommon complication of maternal COVID-19. Placenta. 2021;104:261-6. https://doi.org/10.1016/j.placenta.2021.01.012 PMid:33465727 PMCid:PMC7832228
(19) Cooper AJ, Sequist LV, Lin JJ. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management [published correction appears in Nat Rev Clin Oncol. 2022 Nov;19(11):744]. Nat Rev Clin Oncol. 2022;19(8):499-514. https://doi.org/10.1038/s41571-022-00639-9 PMid:35534623 PMCid:PMC9621058
Published
Abstract Display: 555 
PDF Downloads: 413 PDF Downloads: 20 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.